Clinical Trial Update: Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection [Phase 1, Phase 2]

View source ↗

Summary

This document notes an ongoing Phase 1/2 clinical trial evaluating intra-arterial bevacizumab for chronic subdural hematoma. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: The Cooper Health System | Conditions: Chronic Subdural Hematoma | Phase 1, Phase 2 | Status: RECRUITING